HealthStream (HSTM) Earnings Analysis
HealthStream (HSTM) next reports earnings on 2026-08-03, consensus EPS 0.17 USD. Last quarter (2026-05-04) it beat with EPS 0.2 USD vs 0.16 USD est (+25%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E 40.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HSTM next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | 0.17 USD |
| Revenue estimate | 0.08B |
HSTM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 0.2 USD | 0.16 USD | +25% | Beat |
| 2026-02-23 | 0.18 USD | 0.16 USD | +12.5% | Beat |
| 2025-11-03 | 0.2 USD | 0.17 USD | +17.6% | Beat |
| 2025-08-04 | 0.18 USD | 0.16 USD | +12.5% | Beat |
| 2025-05-05 | 0.14 USD | 0.16 USD | -12.5% | Miss |
| 2025-02-24 | 0.16 USD | 0.13 USD | +23.1% | Beat |
| 2024-10-21 | 0.19 USD | 0.13 USD | +46.2% | Beat |
Beat rate: 6/7 (86%) over reported quarters with consensus data.
HSTM valuation and analyst view
| Trailing P/E | 40.40 |
|---|---|
| Trailing EPS | 0.6781 USD |
| Price / book | 2.24 |
| Dividend yield | 0.49% |
| Market cap | 0.80B |
| Analyst consensus | Hold (7 buy / 9 hold / 0 sell) |
| Avg price target | 25.5 USD |
Related research pages
Frequently asked questions
When is HealthStream (HSTM)'s next earnings date?
HealthStream is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 0.17 USD and revenue estimate of 0.08B.
Did HSTM beat earnings last quarter?
In its 2026-05-04 report, HSTM posted EPS of 0.2 USD versus a 0.16 USD estimate — a beat of 25%.
What is HSTM's earnings track record?
Over the last 7 reported quarters with consensus data, HSTM beat estimates 6 times (86%).
What is HSTM's current P/E ratio and EPS?
HSTM trades at a trailing P/E of 40.40 on trailing EPS of 0.6781045751633987 USD.
What do analysts rate HSTM?
Analyst consensus is "Hold" across 16 ratings (0 strong buy, 7 buy, 9 hold, 0 sell, 0 strong sell). Average 12-month price target: 25.5 USD.